해부 병리학 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 동향 및 예측(2026-2034년)

Growth Factors of anatomic pathology Market

The global anatomic pathology market was valued at USD 37.74 billion in 2025 and is projected to grow from USD 40.29 billion in 2026 to USD 74.04 billion by 2034, registering a CAGR of 7.90% during the forecast period. North America dominated the global market with a 36.18% market share in 2025, supported by advanced healthcare infrastructure, high diagnostic test volumes, and rapid adoption of digital pathology technologies.

Anatomic pathology is a specialized branch of medicine that diagnoses diseases by examining tissues, organs, and cells. It plays a critical role in identifying chronic diseases such as cancer, inflammatory disorders, and autoimmune conditions. Rising incidences of chronic illnesses, increasing cancer screening programs, and growing demand for personalized medicine are significantly driving the adoption of histopathology, immunohistochemistry (IHC), molecular pathology, and digital pathology solutions. Moreover, increasing investments in research and development, technological advancements, and favorable government initiatives aimed at strengthening diagnostic capabilities are expected to fuel market expansion throughout the forecast period.

Growing Burden of Chronic Diseases Driving Market Expansion

The increasing prevalence of chronic diseases remains one of the strongest growth drivers for the anatomic pathology market. According to the American Cancer Society, nearly 2 million new cancer cases are expected to be diagnosed in the U.S. during 2025, creating substantial demand for pathology testing and tissue-based diagnostics. Histopathology and immunohistochemistry continue to serve as the gold standard for cancer diagnosis, enabling physicians to make accurate treatment decisions.

Additionally, the growing incidence of inflammatory bowel disease, autoimmune disorders, and infectious diseases is further increasing pathology test volumes worldwide. Governments and healthcare organizations are expanding screening initiatives and improving laboratory infrastructure, accelerating product adoption across hospitals and diagnostic laboratories.

Technological Advancements Transforming Diagnostic Workflows

Rapid technological innovation has become a defining trend in the global anatomic pathology market. The integration of artificial intelligence (AI), digital pathology, molecular diagnostics, whole-slide imaging, and automated tissue processing systems is improving diagnostic accuracy while reducing turnaround times.

Digital pathology platforms allow remote consultations, AI-assisted image analysis, and efficient laboratory workflows. Major companies are investing heavily in next-generation pathology solutions to improve productivity and diagnostic precision. Increasing adoption of cloud-based pathology platforms and AI-enabled decision support systems is expected to reshape pathology laboratories during the forecast period.

High Equipment Costs Continue to Challenge Market Growth

Despite strong market demand, the high cost of advanced pathology instruments remains a significant challenge. Digital pathology scanners, automated tissue processors, molecular diagnostic platforms, and AI-enabled systems require substantial capital investment, limiting adoption among small and mid-sized laboratories.

Developing countries also face shortages of skilled pathologists, limited laboratory infrastructure, reimbursement challenges, and regulatory barriers that delay technology adoption. These factors may restrict market penetration, particularly across emerging economies.

Market Segmentation

Based on type, the products segment is expected to dominate the global market with a 63.13% share in 2026, driven by increasing demand for technologically advanced pathology instruments and consumables.

By application, the disease diagnosis segment will account for 71.64% of the market in 2026, supported by rising cancer incidence and increasing diagnostic testing.

Based on technique, histopathology is projected to lead the market with a 45.62% share in 2026, owing to its extensive use in diagnosing cancer and chronic diseases.

By end-user, hospitals & ambulatory surgery centers (ASCs) are expected to dominate with a 56.54% market share in 2026, supported by growing patient admissions, increasing surgical procedures, and expanding hospital infrastructure worldwide.

Regional Analysis

North America remained the leading regional market with a value of USD 13.65 billion in 2025 and is projected to reach USD 14.63 billion in 2026. The region benefits from advanced healthcare infrastructure, widespread adoption of digital pathology, strong reimbursement systems, and continuous product innovations. The U.S. market alone is estimated to reach USD 12.69 billion in 2026.

Europe continues to witness steady growth due to increasing adoption of digital pathology systems, favorable government initiatives, and expanding cancer screening programs. The regional market is projected to reach USD 9.98 billion in 2026.

Asia Pacific accounted for USD 11.07 billion in 2025 and is projected to grow to USD 11.78 billion in 2026, driven by rising chronic disease prevalence, improving healthcare infrastructure, and expanding access to diagnostic services across China, India, and Japan.

Latin America generated USD 2.38 billion in 2025 and is expected to reach USD 2.53 billion in 2026, while the Middle East & Africa market is projected to grow from USD 1.30 billion in 2025 to USD 1.38 billion in 2026, supported by healthcare modernization initiatives and increasing awareness regarding early disease diagnosis.

Competitive Landscape

The global anatomic pathology market remains highly competitive, with leading companies continuously investing in product innovation, acquisitions, and regulatory approvals to strengthen their market positions. Major industry participants include Cardinal Health, F. Hoffmann-La Roche Ltd., Avantor Inc., Danaher Corporation, SLMP, LLC., Agilent Technologies, Inc., Indica Labs, LLC., and Hologic, Inc.

Recent industry developments highlight the rapid pace of innovation. In September 2025, Labcorp partnered with F. Hoffmann-La Roche Ltd. to implement Roche's FDA-cleared digital pathology slide scanners. In July 2025, PathAI introduced its Precision Pathology Network to strengthen digital pathology workflows, while Techcyte launched its Fusion SaaS platform to integrate anatomic and clinical pathology operations. Earlier, StatLab Medical Products expanded its global footprint through the acquisition of Diapath S.p.A., strengthening its histology product portfolio.

Conclusion

The global anatomic pathology market is poised for sustained growth over the forecast period, driven by rising prevalence of chronic diseases, increasing cancer diagnosis rates, expanding digital pathology adoption, and continuous technological advancements. Growing investments in AI-enabled diagnostics, precision medicine, and laboratory automation are expected to further transform pathology workflows worldwide. Although high equipment costs and limited access to skilled professionals remain key challenges in developing regions, expanding healthcare infrastructure, supportive government initiatives, and continuous product innovation are expected to create significant growth opportunities, positioning the market for strong long-term expansion through 2034.

Segmentation By Type

• Products
  • Instruments
• Microtomes
• Tissue Processing Systems
• Stainers
• Others
  • Consumables
• Services

By Application

• Disease Diagnosis
• Drug Discovery
• Others

By Technique

• Histopathology
• Immunohistochemistry (IHC)
• In-situ Hybridization
• Molecular Pathology
• Others

By End User

• Hospitals & ASCs
• Specialty Clinics
• Clinical Laboratories
• Others

By Region

• North America (By Type, By Application, By Technique, By End User, and by Country)
  • U.S. (By Application)
  • Canada (By Application)
• Europe (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • U.K. (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Scandinavia (By Application)
  • Rest of Europe (By Application)
• Asia Pacific (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • China (By Application)
  • Japan (By Application)
  • India (By Application)
  • Australia (By Application)
  • Southeast Asia (By Application)
  • Rest of Asia Pacific (By Application)
• Latin America (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • Brazil (By Application)
  • Mexico (By Application)
  • Rest of Latin America (By Application)
• Middle East & Africa (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • GCC (By Application)
  • South Africa (By Application)
  • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
• 4.2. New Product Launches, Key Players
• 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Products
    • 5.1.1.1. Instruments
      • 5.1.1.1.1. Microtomes
      • 5.1.1.1.2. Tissue Processing Systems
      • 5.1.1.1.3. Stainers
      • 5.1.1.1.4. Others
    • 5.1.1.2. Consumables
  • 5.1.2. Services
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Disease Diagnosis
  • 5.2.2. Drug Discovery
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Technique
  • 5.3.1. Histopathology
  • 5.3.2. Immunohistochemistry (IHC)
  • 5.3.3. In-situ Hybridization
  • 5.3.4. Molecular Pathology
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Specialty Clinics
  • 5.4.3. Clinical Laboratories
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Products
    • 6.1.1.1. Instruments
      • 6.1.1.1.1. Microtomes
      • 6.1.1.1.2. Tissue Processing Systems
      • 6.1.1.1.3. Stainers
      • 6.1.1.1.4. Others
    • 6.1.1.2. Consumables
  • 6.1.2. Services
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Disease Diagnosis
  • 6.2.2. Drug Discovery
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Technique
  • 6.3.1. Histopathology
  • 6.3.2. Immunohistochemistry (IHC)
  • 6.3.3. In-situ Hybridization
  • 6.3.4. Molecular Pathology
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Specialty Clinics
  • 6.4.3. Clinical Laboratories
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Application
  • 6.5.2. Canada
    • 6.5.2.1. By Application

7. Europe Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Products
    • 7.1.1.1. Instruments
      • 7.1.1.1.1. Microtomes
      • 7.1.1.1.2. Tissue Processing Systems
      • 7.1.1.1.3. Stainers
      • 7.1.1.1.4. Others
    • 7.1.1.2. Consumables
  • 7.1.2. Services
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Disease Diagnosis
  • 7.2.2. Drug Discovery
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Technique
  • 7.3.1. Histopathology
  • 7.3.2. Immunohistochemistry (IHC)
  • 7.3.3. In-situ Hybridization
  • 7.3.4. Molecular Pathology
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Specialty Clinics
  • 7.4.3. Clinical Laboratories
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Application
  • 7.5.2. Germany
    • 7.5.2.1. By Application
  • 7.5.3. France
    • 7.5.3.1. By Application
  • 7.5.4. Spain
    • 7.5.4.1. By Application
  • 7.5.5. Italy
    • 7.5.5.1. By Application
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Application
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Application

8. Asia Pacific Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Products
    • 8.1.1.1. Instruments
      • 8.1.1.1.1. Microtomes
      • 8.1.1.1.2. Tissue Processing Systems
      • 8.1.1.1.3. Stainers
      • 8.1.1.1.4. Others
    • 8.1.1.2. Consumables
  • 8.1.2. Services
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Disease Diagnosis
  • 8.2.2. Drug Discovery
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Technique
  • 8.3.1. Histopathology
  • 8.3.2. Immunohistochemistry (IHC)
  • 8.3.3. In-situ Hybridization
  • 8.3.4. Molecular Pathology
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Specialty Clinics
  • 8.4.3. Clinical Laboratories
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Application
  • 8.5.2. Australia
    • 8.5.2.1. By Application
  • 8.5.3. China
    • 8.5.3.1. By Application
  • 8.5.4. India
    • 8.5.4.1. By Application
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Application
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Application

9. Latin America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Products
    • 9.1.1.1. Instruments
      • 9.1.1.1.1. Microtomes
      • 9.1.1.1.2. Tissue Processing Systems
      • 9.1.1.1.3. Stainers
      • 9.1.1.1.4. Others
    • 9.1.1.2. Consumables
  • 9.1.2. Services
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Disease Diagnosis
  • 9.2.2. Drug Discovery
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Technique
  • 9.3.1. Histopathology
  • 9.3.2. Immunohistochemistry (IHC)
  • 9.3.3. In-situ Hybridization
  • 9.3.4. Molecular Pathology
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Specialty Clinics
  • 9.4.3. Clinical Laboratories
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Application
  • 9.5.2. Mexico
    • 9.5.2.1. By Application
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Application

10. Middle East & Africa Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Products
    • 10.1.1.1. Instruments
      • 10.1.1.1.1. Microtomes
      • 10.1.1.1.2. Tissue Processing Systems
      • 10.1.1.1.3. Stainers
      • 10.1.1.1.4. Others
    • 10.1.1.2. Consumables
  • 10.1.2. Services
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Disease Diagnosis
  • 10.2.2. Drug Discovery
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Technique
  • 10.3.1. Histopathology
  • 10.3.2. Immunohistochemistry (IHC)
  • 10.3.3. In-situ Hybridization
  • 10.3.4. Molecular Pathology
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Specialty Clinics
  • 10.4.3. Clinical Laboratories
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
    • 10.5.1.1. By Application
  • 10.5.2. South Africa
    • 10.5.2.1. By Application
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Application

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Cardinal Health
  • 11.2.2. F. Hoffmann La. Roche Ltd.
  • 11.2.3. Avantor, Inc.
  • 11.2.4. Danaher Corporation
  • 11.2.5. SLMP, LLC.
  • 11.2.6. Agilent Technologies, Inc.
  • 11.2.7. Indica Labs, LLC.
  • 11.2.8. Hologic, Inc.